Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

GBIO stock news

This page provides real-time market news, earnings updates, and company announcements related to Generation Bio Co. (GBIO).

All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.

Last updated as of 2026-02-21 15:52 EST

NVIDIA Corporation (NVDA) to Supply Standalone Grace CPUs in Landmark Data Center Rollout image

NVIDIA Corporation (NVDA) to Supply Standalone Grace CPUs in Landmark Data Center Rollout

Finviz2026-02-20 18:18:04
Alphabet Inc.'s (GOOG) Generative AI Capex to Drive Up to $23B in Cloud Revenue, Says UBS image

Alphabet Inc.'s (GOOG) Generative AI Capex to Drive Up to $23B in Cloud Revenue, Says UBS

Finviz2026-02-20 18:18:04
Alphabet Inc.'s (GOOG) Generative AI Capex to Drive Up to $23B in Cloud Revenue, Says UBS image

Alphabet Inc.'s (GOOG) Generative AI Capex to Drive Up to $23B in Cloud Revenue, Says UBS

Finviz2026-02-20 18:18:04
Cipher Mining Stock Before Q4 Earnings: What's in the Offing? image

Cipher Mining Stock Before Q4 Earnings: What's in the Offing?

Finviz2026-02-20 18:21:43
Rosenblatt Cuts The Walt Disney Company (DIS) PT Despite Q1 Earnings Beat image

Rosenblatt Cuts The Walt Disney Company (DIS) PT Despite Q1 Earnings Beat

Finviz2026-02-20 18:21:44
GE HealthCare Wins FDA Clearances for Next-Gen SIGNA MRI Portfolio image

GE HealthCare Wins FDA Clearances for Next-Gen SIGNA MRI Portfolio

Finviz2026-02-20 18:27:41
Forget Profit, Bet on These 4 Stocks With Increasing Cash Flows image

Forget Profit, Bet on These 4 Stocks With Increasing Cash Flows

Finviz2026-02-20 18:42:38
What's Going On With Envirotech Vehicles Stock Friday? image

What's Going On With Envirotech Vehicles Stock Friday?

Finviz2026-02-20 19:12:50
U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults image

U.S. Food and Drug Administration (FDA) Accepts Teva's New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Finviz2026-02-20 19:48:38
Palo Alto Networks (PANW) to Acquire Koi image

Palo Alto Networks (PANW) to Acquire Koi

Finviz2026-02-20 20:15:42
ServiceNow (NOW) CEO McDermott Bought $3 Million Worth Company Shares, Here's What You Need to Know image

ServiceNow (NOW) CEO McDermott Bought $3 Million Worth Company Shares, Here's What You Need to Know

Finviz2026-02-20 20:15:42
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) image

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Finviz2026-02-20 21:06:42
Oracle Shares Drop 55%: Is This a Buying Opportunity or Time to Avoid? image

Oracle Shares Drop 55%: Is This a Buying Opportunity or Time to Avoid?

101 finance2026-02-20 21:18:42
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment image

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment

Finviz2026-02-20 22:21:43
Caterpillar (CAT) Price Target Raised by BofA as Turbine Demand Broadens image

Caterpillar (CAT) Price Target Raised by BofA as Turbine Demand Broadens

Finviz2026-02-20 23:27:11
After the Pause, the Magnificent 7 Stocks Look Ready to Lead Again image

After the Pause, the Magnificent 7 Stocks Look Ready to Lead Again

Finviz2026-02-20 23:27:12
Goldman Sachs Raises its Price Target on Entegris, Inc. (ENTG) to $95 and Maintains a Sell Rating image

Goldman Sachs Raises its Price Target on Entegris, Inc. (ENTG) to $95 and Maintains a Sell Rating

Finviz2026-02-21 11:12:01
Jefferies Raises its Price Target on The Williams Companies, Inc. (WMB) to $81 and Maintains a Buy Rating image

Jefferies Raises its Price Target on The Williams Companies, Inc. (WMB) to $81 and Maintains a Buy Rating

Finviz2026-02-21 14:42:42
JPMorgan Raises its Price Target on Vistra Corp. (VST) to $239 and Maintains an Overweight Rating image

JPMorgan Raises its Price Target on Vistra Corp. (VST) to $239 and Maintains an Overweight Rating

Finviz2026-02-21 15:36:45
Why Savvy Investors Purchase During AI Stock Dips image

Why Savvy Investors Purchase During AI Stock Dips

101 finance2026-02-21 19:09:08

GBIO stock chart

GBIO stock details

GBIO stock price change

On the last trading day, GBIO stock closed at 5.34 USD, with a price change of -6.97% for the day.

Trade stock futures

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more
GBIO stock news